Potential of epigenetic modifications in the study and treatment of cardiovascular diseases (CVD)

+

The scientific article by Olivier Emery, David Nanchen and Jonviea Chamberlain in Unisanté discusses the potential of epigenetic modifications in the study and treatment of cardiovascular diseases (CVD). It highlights that while genetics plays a role in CVD risk, lifestyle and environment significantly impact epigenetic markers, which could be key in CVD management. Epigenetic signatures, reflecting the cumulative effect of these factors, may inform diagnosis and patient monitoring.

Read the article